View ICR - OIRA Conclusion



0910-0797 201808-0910-003
Historical Inactive 201507-0910-003
HHS/FDA CDER
GFI: Controlled Correspondence Related to Generic Drug Development
Extension without change of a currently approved collection   No
Regular
Improperly submitted and continue 08/22/2018
08/21/2018
According to the supporting statement, the information collection reflects an increase in the number of annual responses based on submissions received, a revision of the companion guidance to align with GDUFA II commitments regarding timeframes and agency goals, AND the establishment of an electronic submission portal to replace submissions by e-mail. As such, this should be submitted as a revision request and not an extension without change. The portal must also be included as an IC in the revision request.
  Inventory as of this Action Requested Previously Approved
09/30/2018 36 Months From Approved 10/31/2018
1,020 0 1,020
5,100 0 5,100
0 0 0